Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Infectious Causes of Chronic Meningitis in Neurosurgical Patients
Infectious Disease
S38 - All Things HIV and ID (4:42 PM-4:54 PM)
007

Chronic meningitis is an uncommon complication of neurosurgery. Some of the most common organisms shown to cause acute meningitis after neurosurgical procedures have been Staphylococcus, Klebsiella, Pseudomonas, and Candida species. Literature regarding chronic meningitis in this population is absent.

To describe the etiologies and mortality of chronic meningitis in neurosurgical patients
This was a retrospective chart review of all patients diagnosed with chronic meningitis at Geisinger Medical Center from 2002 to 2018. Chronic meningitis was defined as the presence of CSF WBC pleocytosis greater than 5 cells/mm3 on two occasions at least 4 weeks apart. We manually extracted data from the electronic medical record for identified cases as approved by the institutional review board (IRB).

25 patients were identified who met inclusion criteria for this period with an antecedent neurosurgical procedure. The age range of the patients was 20-84 years, with a mean of 54.3.  Most commonly CSF cultures were negative (24%), followed by Staphylococcus (20%), Pseudomonas (12%), and Candida (12%). Most common antecedent surgical procedures were craniotomy (48%), ventriculoperitoneal shunt placement/revision (20%), and extraventricular drain placed (16%). 30-day mortality was 12% (3/25).

Risk factors for post-surgical meningitis include increased age, craniotomy, and CSF leak. CSF leak and craniotomy were associated with the deaths in our series. In patients with a bacterial etiology, the majority (60%) were from gram-positive organisms, which correlates with current literature showing a greater predominance of gram-positive organisms in these infections. Organisms grown in our patients were similar to previous studies on acute meningitis. Nearly half of our patients had a craniotomy, suggesting this is a risk factor for chronic meningitis in addition to acute meningitis. Our data demonstrated a lower mortality (12%) in neurosurgical chronic meningitis than has been reported for acute neurosurgical meningitis (22%-36%).

Authors/Disclosures
Tyler Crissinger, MD (Maine Health)
PRESENTER
Dr. Crissinger has nothing to disclose.
Joseph Seemiller, MD Dr. Seemiller has nothing to disclose.
John Herbst, DO (Allegheny Health Network Cancer Institute) Dr. Herbst has nothing to disclose.
J. David Avila, MD (Geisinger Medical Center) Dr. Avila has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Avila has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda.
Kelly Baldwin, MD (Evangelical Community Hospital) Dr. Baldwin has nothing to disclose.